Cargando…
The GHB analogue HOCPCA improves deficits in cognition and sensorimotor function after MCAO via CaMKIIα
Ca(2+)/calmodulin-dependent protein kinase II alpha (CaMKIIα) is a major contributor to physiological and pathological glutamate-mediated Ca(2+) signals, and its involvement in various critical cellular pathways demands specific pharmacological strategies. We recently presented γ-hydroxybutyrate (GH...
Autores principales: | Griem-Krey, Nane, Klein, Anders B, Clausen, Bettina H, Namini, Mathias RJ, Nielsen, Pernille V, Bhuiyan, Mozammel, Nagaraja, Raghavendra Y, De Silva, T Michael, Sobey, Christopher G, Cheng, Heung-Chin, Orset, Cyrille, Vivien, Denis, Lambertsen, Kate L, Clarkson, Andrew N, Wellendorph, Petrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369146/ https://www.ncbi.nlm.nih.gov/pubmed/37026450 http://dx.doi.org/10.1177/0271678X231167920 |
Ejemplares similares
-
CaMKIIα as a Promising Drug Target for Ischemic Grey Matter
por: Griem-Krey, Nane, et al.
Publicado: (2022) -
GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain
por: Leurs, Ulrike, et al.
Publicado: (2021) -
CaMKII points the way
por: Leslie, Mitch
Publicado: (2012) -
CaMKII in Cardiometabolic Disease
por: Ozcan, Lale, et al.
Publicado: (2014) -
Synaptic memory and CaMKII
por: Nicoll, Roger A., et al.
Publicado: (2023)